Back to MW MARSHALL WACE, LLP

CTMXCTMX
22 quarters

Position history for MWMARSHALL WACE, LLP's holdings in CYTOMX THERAPEUTICS INC.

MARSHALL WACE, LLP holds 3M shares of CTMX (CYTOMX THERAPEUTICS INC.), worth $11.3M as of 2026-Q2. The position was decreased (-26.9% shares). CTMX represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$11.3M

Current Shares

3M

Total Value Change

+$10.6M

Total Shares Change

+3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
3M
-26.9%
$11.3M0.0%$3.75
0
2026-Q1
Increased
4.1M
+257.7%
$19.4M0.0%$4.81
46
2025-Q4
Increased
1.2M
+4.7%
$4.9M0.0%$4.16
28
2025-Q3
Decreased
1.1M
-53.0%
$3.5M0.0%$3.23
0
2025-Q2
Increased
2.4M
+2650.9%
$5.3M0.0%$2.25
44
2025-Q1
New
85,539
-
$54,7460.0%$0.63
29
2024-Q2
Exited
0
-100.0%
$00.0%$1.22
0
2024-Q1
Decreased
52,289
-85.6%
$113,9900.0%$2.18
0
2023-Q4
Decreased
363,276
-3.8%
$563,0780.0%$1.55
0
2023-Q3
Decreased
377,593
-44.0%
$487,0950.0%$1.29
0
2023-Q2
Decreased
674,501
-7.6%
$1.2M0.0%$1.41
0
2023-Q1
New
729,938
-
$1.1M0.0%$1.48
35
2022-Q4
Exited
0
-100.0%
$00.0%$1.60
0
2022-Q3
Decreased
40,021
-37.6%
$58,0000.0%$1.47
0
2022-Q2
Increased
64,144
+320.2%
$118,0000.0%$1.87
35
2022-Q1
New
15,266
-
$40,0000.0%$2.77
28
2020-Q2
Exited
0
-100.0%
$00.0%$8.21
0
2020-Q1
Decreased
117,393
-70.8%
$900,0000.0%$6.70
0
2019-Q4
Increased
401,426
+4902.2%
$3.3M0.0%$8.29
43
2019-Q3
New
8,025
-
$59,0000.0%$7.70
29
2019-Q1
Exited
0
-100.0%
$00.0%$10.75
0
2018-Q4
New
51,876
-
$783,0000.0%$14.97
34

Other major holders of CTMX: FMR LLC, BlackRock, Inc., BNP PARIBAS FINANCIAL MARKETS

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used